CN101693052A - 一种紫灯微丸及其制备方法 - Google Patents
一种紫灯微丸及其制备方法 Download PDFInfo
- Publication number
- CN101693052A CN101693052A CN200910187871A CN200910187871A CN101693052A CN 101693052 A CN101693052 A CN 101693052A CN 200910187871 A CN200910187871 A CN 200910187871A CN 200910187871 A CN200910187871 A CN 200910187871A CN 101693052 A CN101693052 A CN 101693052A
- Authority
- CN
- China
- Prior art keywords
- crude drug
- radix
- weight portion
- violet light
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008188 pellet Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 49
- 229940079593 drug Drugs 0.000 claims abstract description 38
- 239000000203 mixture Substances 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 74
- 239000000284 extract Substances 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000741 silica gel Substances 0.000 claims description 17
- 229910002027 silica gel Inorganic materials 0.000 claims description 17
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 16
- 241000180649 Panax notoginseng Species 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 16
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 15
- 238000010828 elution Methods 0.000 claims description 15
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 15
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 15
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 239000007779 soft material Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 7
- 239000000853 adhesive Substances 0.000 claims description 6
- 230000001070 adhesive effect Effects 0.000 claims description 6
- 230000000274 adsorptive effect Effects 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 238000000280 densification Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 5
- 235000019634 flavors Nutrition 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 229920005989 resin Polymers 0.000 claims description 5
- 239000011347 resin Substances 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 abstract description 20
- 241001013934 Erigeron breviscapus Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000687941 Salvia przewalskii Species 0.000 abstract 1
- 235000008202 Salvia przewalskii Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 238000005303 weighing Methods 0.000 description 9
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 7
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 7
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 7
- 208000000114 Pain Threshold Diseases 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 230000037040 pain threshold Effects 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 239000012567 medical material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 208000036319 cervical spondylosis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005801 spondylosis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101878718A CN101693052B (zh) | 2009-10-15 | 2009-10-15 | 一种紫灯微丸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101878718A CN101693052B (zh) | 2009-10-15 | 2009-10-15 | 一种紫灯微丸及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101693052A true CN101693052A (zh) | 2010-04-14 |
CN101693052B CN101693052B (zh) | 2011-08-17 |
Family
ID=42092078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101878718A Withdrawn - After Issue CN101693052B (zh) | 2009-10-15 | 2009-10-15 | 一种紫灯微丸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101693052B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102204954A (zh) * | 2011-04-27 | 2011-10-05 | 江西普正制药有限公司 | 一种紫灯片及其制备方法 |
CN104814373A (zh) * | 2015-05-19 | 2015-08-05 | 河北金木药业集团有限公司 | 一种含菊苣的组合物、微丸及其制备方法 |
-
2009
- 2009-10-15 CN CN2009101878718A patent/CN101693052B/zh not_active Withdrawn - After Issue
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102204954A (zh) * | 2011-04-27 | 2011-10-05 | 江西普正制药有限公司 | 一种紫灯片及其制备方法 |
CN102204954B (zh) * | 2011-04-27 | 2013-03-06 | 江西普正制药有限公司 | 一种紫灯片及其制备方法 |
CN104814373A (zh) * | 2015-05-19 | 2015-08-05 | 河北金木药业集团有限公司 | 一种含菊苣的组合物、微丸及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101693052B (zh) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101850066B (zh) | 中药组合物颗粒剂及其制备方法 | |
CN112972547A (zh) | 一种治疗气血两虚症候的中药组合物及其制备方法和应用 | |
CN100374120C (zh) | 灯盏细辛酚及其制备方法和在制药中的应用 | |
CN101085000A (zh) | 一种含丹酚酸b的复方丹参冻干粉针剂及其制备方法 | |
CN1739714A (zh) | 补肾益气的中药制剂及其制备方法和质量控制方法 | |
CN100469377C (zh) | 一种治疗前列腺炎的软胶囊 | |
CN102579554A (zh) | 花生茎叶提取物及其制备方法用途 | |
CN101693052B (zh) | 一种紫灯微丸及其制备方法 | |
CN105535428A (zh) | 一种天王补心制剂的制作方法 | |
CN102920964B (zh) | 一种治疗咳嗽的中药制剂 | |
CN105031005A (zh) | 一种补气益血的微丸 | |
CN101085001B (zh) | 一种含丹参素的复方丹参冻干粉针剂及其制备方法 | |
CN102579530A (zh) | 具有抗糖尿病作用的太白楤木总皂苷的制备方法及药物 | |
CN101904894B (zh) | 独一味总苷在制备药物中的用途 | |
CN107569528A (zh) | 一种治疗肝炎的药物组合物、药物制剂及应用和制备方法 | |
CN100428942C (zh) | 一种养心安神药物及其制备方法 | |
CN101647956B (zh) | 一种治疗瘟疠疾病的药物及其制备方法 | |
CN113058013A (zh) | 一种中药组合物及其制备方法和应用 | |
CN1695728A (zh) | 滋肾养肺的中药口服制剂及其制备方法 | |
CN102058685A (zh) | 一种用于止痛消肿的青鹏涂膜剂及其制备方法 | |
CN103505498A (zh) | 胡芦巴总黄酮有效部位制备及应用 | |
CN101322762B (zh) | 一种治疗糖尿病的药物组合物 | |
CN101084999B (zh) | 一种含三七的复方丹参冻干粉针剂及其制备方法 | |
CN101084998B (zh) | 一种复方丹参冻干粉针剂 | |
CN1150918C (zh) | 珠子参有效成份制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Gao Dan Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right |
Effective date of registration: 20200102 Address after: 100124 1605, floor 13, building 3, No. 82, East Fourth Ring Middle Road, Chaoyang District, Beijing Patentee after: Beijing Huayao Kechuang Pharmaceutical Technology Development Co.,Ltd. Address before: 110179 Liaoning province Shenyang Hunnan New Long Street No. 10-1 Co-patentee before: Guan Yi Patentee before: Shenyang Yiling Pharmaceutical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
AV01 | Patent right actively abandoned |
Granted publication date: 20110817 Effective date of abandoning: 20230714 |
|
AV01 | Patent right actively abandoned |
Granted publication date: 20110817 Effective date of abandoning: 20230714 |
|
AV01 | Patent right actively abandoned | ||
AV01 | Patent right actively abandoned |